SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Thyrocare Technologies launching blood-based cancer screening profile

17 Feb 2020 Evaluate

Thyrocare Technologies is launching Blood-based Cancer Screening Profile. This consists of Easycheck360, a cancer screening test profile for early detection of 16 types of cancers, processed by Datar Cancer Genetics (Dater) and Thyrocare's popular wellness profile Aarogyam which is available for Rs 8,999.

Cancer screening through blood is a breakthrough and patented technology, pioneered by 'Dater' which is clinically proven in the world's largest study with over 44,000 subjects. The research data has been published and acknowledged by the International Journal of Cancer and other leading cancer journals.

Thyrocare Technologies provides hospital services and are the industry leader, trend setter and innovators in Indian Diagnostic industry.

Thyrocare Tech. Share Price

395.50 7.65 (1.97%)
22-Apr-2026 13:03 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×